- Published on
Emergency And Acute Medicine – Congestive Heart Failure
Description
Congestive heart failure is a clinical syndrome in which the heart is unable to maintain adequate circulation to meet metabolic demands. It is characterized by chronic debility, episodes of acute decompensation, and high mortality. Acute decompensated heart failure is a rapidly progressive state developing over hours to days and is a common reason for emergency department presentation, often triggered by a precipitating event that exceeds the heart’s compensatory reserve. Chronic heart failure is a progressive condition evolving over months to years, marked by cardiac remodeling and neurohormonal activation. Subtypes include systolic heart failure with impaired contractility and reduced ejection fraction, diastolic heart failure with impaired ventricular relaxation and filling, low-output failure, high-output failure in which cardiac output is normal or increased but insufficient for metabolic needs, left-sided failure with pulmonary congestion, and right-sided failure characterized by hepatic enlargement, jugular venous distention, and dependent edema. Congestive heart failure affects approximately 5.8 million Americans and represents a major cause of hospitalization and healthcare expenditure.
Etiology
Heart failure results from underlying cardiac disease and acute precipitants. Causes include reduced myocardial contractility from ischemia or infarction, cardiomyopathies, myocarditis, and dysrhythmias; reduced contractile efficiency from medications or metabolic disorders; pressure overload from hypertension, valvular disease, congenital heart disease, pulmonary embolism, or pulmonary hypertension; restricted cardiac output due to infiltrative myocardial disease; volume overload from dietary sodium excess, transfusions, intravenous fluids, or sodium-retaining medications; and high-demand states such as hyperthyroidism, pregnancy, anemia, arteriovenous fistula, beriberi, and Paget disease. Pediatric causes vary by age and include congenital shunt lesions in infancy and acquired myocardial dysfunction in older children and adolescents.
Clinical Features
Symptoms reflect poor perfusion and congestion. Poor perfusion manifests as fatigue, somnolence, lightheadedness, palpitations, cool extremities, worsening renal function, and dyspnea. Congestion presents with exertional dyspnea, cough, orthopnea, paroxysmal nocturnal dyspnea, decreased exercise tolerance, elevated jugular venous pressure, dependent edema, rales or wheezing, pleural effusions, third or fourth heart sounds, displaced apical impulse, hepatic enlargement, nausea, and ascites. Acute decompensated heart failure with hemodynamic instability may cause confusion, anxiety, syncope, tachypnea, tachycardia, hypotension, cool or cyanotic extremities, narrow pulse pressure, pulsus alternans, and Cheyne–Stokes respirations.
Essential Diagnostic Evaluation
Chest radiography is central to confirming the diagnosis and assessing severity, although radiographic changes may lag behind symptom onset and persist after clinical improvement. Continuous reassessment is required.
Diagnostic Tests And Interpretation
Laboratory studies include electrolytes and renal function to establish baseline and guide therapy, complete blood count to assess anemia or infection, liver function tests for hepatic congestion or ischemia, thyroid function tests in older patients or those with atrial fibrillation, and cardiac enzymes to evaluate ischemia. B-type natriuretic peptide is useful for differentiating cardiac from pulmonary causes of dyspnea, with high values supporting heart failure and low values making it unlikely, though interpretation must consider age, obesity, and comorbidities. NT-proBNP may also aid diagnosis. Imaging with chest radiography may reveal cardiomegaly, vascular redistribution, interstitial or alveolar edema, pleural effusions, and classic perihilar patterns. Electrocardiography evaluates ischemia, dysrhythmias, hypertrophy, and conduction abnormalities. Echocardiography provides assessment of ejection fraction, ventricular size, valvular pathology, regional wall motion abnormalities, and pericardial disease.
Differential Diagnosis
Left-sided heart failure must be distinguished from acute exacerbations of chronic obstructive pulmonary disease, asthma, pneumonia, acute respiratory distress syndrome, constrictive pericarditis, anemia, malnutrition, pericardial tamponade, and coarctation of the aorta. Right-sided failure may mimic nephrotic syndrome, chronic renal failure, cirrhosis, pulmonary embolism, sleep-disordered breathing, or venous stasis.
Initial Stabilization And Therapy
Management begins with airway assessment, supplemental oxygen, intravenous access, cardiac monitoring, and electrocardiography. Elevating the head of the bed reduces venous return. Noninvasive positive pressure ventilation is often beneficial to reduce work of breathing and improve oxygenation, while intubation is reserved for impending respiratory failure.
Emergency Department Management
Treatment focuses on optimizing oxygenation, ventilation, and hemodynamics while addressing the underlying cause. In patients with congestion and adequate perfusion, preload reduction with nitrates and cautious diuretic therapy is appropriate, particularly in acute pulmonary edema. Afterload reduction must be used carefully and avoided in hypotension, acute renal failure, or hyperkalemia. In patients with poor perfusion and hypotension, inotropic support with agents such as dobutamine, dopamine, or milrinone is indicated, with diuretics added after stabilization. Vasodilators should be avoided in shock states. Venous thromboembolism prophylaxis should be considered when appropriate. Pediatric management varies by age and may require prostaglandin infusion in ductal-dependent lesions.
Medications
Common agents include loop diuretics, nitrates, inotropes, vasodilators, angiotensin-converting enzyme inhibitors when appropriate, and adjunctive therapies based on etiology. Medication selection and dosing should be individualized based on hemodynamic status and comorbidities.
Disposition And Follow-Up
Admission to the intensive care unit is required for pulmonary edema, cardiogenic shock, or concomitant ischemia. Medical ward admission is indicated for new-onset heart failure or symptoms refractory to emergency treatment. Discharge may be considered in mild exacerbations that respond well to therapy, provided close follow-up is arranged.
Follow-Up Recommendations
Patients require close outpatient follow-up within one week, education on medication adherence and dietary sodium restriction, monitoring of body weight, and regular assessment of renal function and electrolytes.
Clinical Pearls And Pitfalls
B-type natriuretic peptide is helpful when the diagnosis is uncertain but should not be used in isolation. Early use of noninvasive ventilation can prevent respiratory deterioration. Identifying and treating the precipitating cause of decompensation, such as ischemia, arrhythmia, pulmonary embolism, or valvular disease, is essential to successful management.
Description
Congestive heart failure is a clinical syndrome in which the heart is unable to maintain adequate circulation to meet metabolic demands. It is characterized by chronic debility, episodes of acute decompensation, and high mortality. Acute decompensated heart failure is a rapidly progressive state developing over hours to days and is a common reason for emergency department presentation, often triggered by a precipitating event that exceeds the heart’s compensatory reserve. Chronic heart failure is a progressive condition evolving over months to years, marked by cardiac remodeling and neurohormonal activation. Subtypes include systolic heart failure with impaired contractility and reduced ejection fraction, diastolic heart failure with impaired ventricular relaxation and filling, low-output failure, high-output failure in which cardiac output is normal or increased but insufficient for metabolic needs, left-sided failure with pulmonary congestion, and right-sided failure characterized by hepatic enlargement, jugular venous distention, and dependent edema. Congestive heart failure affects approximately 5.8 million Americans and represents a major cause of hospitalization and healthcare expenditure.
Etiology
Heart failure results from underlying cardiac disease and acute precipitants. Causes include reduced myocardial contractility from ischemia or infarction, cardiomyopathies, myocarditis, and dysrhythmias; reduced contractile efficiency from medications or metabolic disorders; pressure overload from hypertension, valvular disease, congenital heart disease, pulmonary embolism, or pulmonary hypertension; restricted cardiac output due to infiltrative myocardial disease; volume overload from dietary sodium excess, transfusions, intravenous fluids, or sodium-retaining medications; and high-demand states such as hyperthyroidism, pregnancy, anemia, arteriovenous fistula, beriberi, and Paget disease. Pediatric causes vary by age and include congenital shunt lesions in infancy and acquired myocardial dysfunction in older children and adolescents.
Clinical Features
Symptoms reflect poor perfusion and congestion. Poor perfusion manifests as fatigue, somnolence, lightheadedness, palpitations, cool extremities, worsening renal function, and dyspnea. Congestion presents with exertional dyspnea, cough, orthopnea, paroxysmal nocturnal dyspnea, decreased exercise tolerance, elevated jugular venous pressure, dependent edema, rales or wheezing, pleural effusions, third or fourth heart sounds, displaced apical impulse, hepatic enlargement, nausea, and ascites. Acute decompensated heart failure with hemodynamic instability may cause confusion, anxiety, syncope, tachypnea, tachycardia, hypotension, cool or cyanotic extremities, narrow pulse pressure, pulsus alternans, and Cheyne–Stokes respirations.
Essential Diagnostic Evaluation
Chest radiography is central to confirming the diagnosis and assessing severity, although radiographic changes may lag behind symptom onset and persist after clinical improvement. Continuous reassessment is required.
Diagnostic Tests And Interpretation
Laboratory studies include electrolytes and renal function to establish baseline and guide therapy, complete blood count to assess anemia or infection, liver function tests for hepatic congestion or ischemia, thyroid function tests in older patients or those with atrial fibrillation, and cardiac enzymes to evaluate ischemia. B-type natriuretic peptide is useful for differentiating cardiac from pulmonary causes of dyspnea, with high values supporting heart failure and low values making it unlikely, though interpretation must consider age, obesity, and comorbidities. NT-proBNP may also aid diagnosis. Imaging with chest radiography may reveal cardiomegaly, vascular redistribution, interstitial or alveolar edema, pleural effusions, and classic perihilar patterns. Electrocardiography evaluates ischemia, dysrhythmias, hypertrophy, and conduction abnormalities. Echocardiography provides assessment of ejection fraction, ventricular size, valvular pathology, regional wall motion abnormalities, and pericardial disease.
Differential Diagnosis
Left-sided heart failure must be distinguished from acute exacerbations of chronic obstructive pulmonary disease, asthma, pneumonia, acute respiratory distress syndrome, constrictive pericarditis, anemia, malnutrition, pericardial tamponade, and coarctation of the aorta. Right-sided failure may mimic nephrotic syndrome, chronic renal failure, cirrhosis, pulmonary embolism, sleep-disordered breathing, or venous stasis.
Initial Stabilization And Therapy
Management begins with airway assessment, supplemental oxygen, intravenous access, cardiac monitoring, and electrocardiography. Elevating the head of the bed reduces venous return. Noninvasive positive pressure ventilation is often beneficial to reduce work of breathing and improve oxygenation, while intubation is reserved for impending respiratory failure.
Emergency Department Management
Treatment focuses on optimizing oxygenation, ventilation, and hemodynamics while addressing the underlying cause. In patients with congestion and adequate perfusion, preload reduction with nitrates and cautious diuretic therapy is appropriate, particularly in acute pulmonary edema. Afterload reduction must be used carefully and avoided in hypotension, acute renal failure, or hyperkalemia. In patients with poor perfusion and hypotension, inotropic support with agents such as dobutamine, dopamine, or milrinone is indicated, with diuretics added after stabilization. Vasodilators should be avoided in shock states. Venous thromboembolism prophylaxis should be considered when appropriate. Pediatric management varies by age and may require prostaglandin infusion in ductal-dependent lesions.
Medications
Common agents include loop diuretics, nitrates, inotropes, vasodilators, angiotensin-converting enzyme inhibitors when appropriate, and adjunctive therapies based on etiology. Medication selection and dosing should be individualized based on hemodynamic status and comorbidities.
Disposition And Follow-Up
Admission to the intensive care unit is required for pulmonary edema, cardiogenic shock, or concomitant ischemia. Medical ward admission is indicated for new-onset heart failure or symptoms refractory to emergency treatment. Discharge may be considered in mild exacerbations that respond well to therapy, provided close follow-up is arranged.
Follow-Up Recommendations
Patients require close outpatient follow-up within one week, education on medication adherence and dietary sodium restriction, monitoring of body weight, and regular assessment of renal function and electrolytes.
Clinical Pearls And Pitfalls
B-type natriuretic peptide is helpful when the diagnosis is uncertain but should not be used in isolation. Early use of noninvasive ventilation can prevent respiratory deterioration. Identifying and treating the precipitating cause of decompensation, such as ischemia, arrhythmia, pulmonary embolism, or valvular disease, is essential to successful management.
0 Comments
